Sequential Analysis of Myeloperoxidase for Prediction of Adverse Events After Suspected Acute Coronary Ischemia. Issue 12 (17th November 2014)
- Record Type:
- Journal Article
- Title:
- Sequential Analysis of Myeloperoxidase for Prediction of Adverse Events After Suspected Acute Coronary Ischemia. Issue 12 (17th November 2014)
- Main Title:
- Sequential Analysis of Myeloperoxidase for Prediction of Adverse Events After Suspected Acute Coronary Ischemia
- Authors:
- Koch, Christian
Henrich, Michael
Heidt, Martin Clemens - Abstract:
- <abstract abstract-type="main" id="clc22336-abs-0001"> <title>Abstract</title> <sec id="clc22336-sec-0001" sec-type="section"> <title>Background</title> <p id="clc22336-para-0001">Myeloperoxidase (MPO) plasma values predict major adverse cardiac events (MACE) in cases of acute coronary syndrome. The effect of serial testing in patients who are suspected for acute coronary ischemia is unclear.</p> </sec> <sec id="clc22336-sec-0002s" sec-type="section"> <title>Hypothesis</title> <p>We hypothesize that sequential MPO measurement may improve prediction of MACE in patients with suspected acute coronary ischemia.</p> </sec> <sec id="clc22336-sec-0002" sec-type="section"> <title>Methods</title> <p id="clc22336-para-0002">The present prospective observational study examined the prognostic significance of MPO in 917 patients with suspicion of acute coronary syndrome. Blood samples were taken at cardiac catheter laboratory admission and the day after coronary angiography. We recorded patients' mortality, the occurrence of cardiac ischemia, and repeated percutaneous coronary intervention through the next 6 months.</p> </sec> <sec id="clc22336-sec-0003" sec-type="section"> <title>Results</title> <p id="clc22336-para-0003">Mortality among patients with increased MPO plasma levels the day after coronary angiography was increased significantly (<italic>P</italic> &lt; 0.01). Patients with MPO values above 306.3 pmol/L had a significantly higher incidence of 6‐month MACE (<italic>P</italic><abstract abstract-type="main" id="clc22336-abs-0001"> <title>Abstract</title> <sec id="clc22336-sec-0001" sec-type="section"> <title>Background</title> <p id="clc22336-para-0001">Myeloperoxidase (MPO) plasma values predict major adverse cardiac events (MACE) in cases of acute coronary syndrome. The effect of serial testing in patients who are suspected for acute coronary ischemia is unclear.</p> </sec> <sec id="clc22336-sec-0002s" sec-type="section"> <title>Hypothesis</title> <p>We hypothesize that sequential MPO measurement may improve prediction of MACE in patients with suspected acute coronary ischemia.</p> </sec> <sec id="clc22336-sec-0002" sec-type="section"> <title>Methods</title> <p id="clc22336-para-0002">The present prospective observational study examined the prognostic significance of MPO in 917 patients with suspicion of acute coronary syndrome. Blood samples were taken at cardiac catheter laboratory admission and the day after coronary angiography. We recorded patients' mortality, the occurrence of cardiac ischemia, and repeated percutaneous coronary intervention through the next 6 months.</p> </sec> <sec id="clc22336-sec-0003" sec-type="section"> <title>Results</title> <p id="clc22336-para-0003">Mortality among patients with increased MPO plasma levels the day after coronary angiography was increased significantly (<italic>P</italic> &lt; 0.01). Patients with MPO values above 306.3 pmol/L had a significantly higher incidence of 6‐month MACE (<italic>P</italic> &lt; 0.0001) than patients with lower plasma values. Cox proportional hazards multivariate regression analyses revealed that MPO was an independent marker for MACE after suspected acute coronary ischemia (<italic>P</italic> = 0.048). However, MPO plasma levels at cardiac catheter laboratory admission showed no prognostic significance.</p> </sec> <sec id="clc22336-sec-0004" sec-type="section"> <title>Conclusions</title> <p id="clc22336-para-0004">In patients with suspected myocardial infarction, MPO levels above 306.3 pmol/L measured 24 hours after onset of symptoms were independent predictors of 6‐month mortality and MACE.</p> </sec> </abstract> … (more)
- Is Part Of:
- Clinical cardiology. Volume 37:Issue 12(2014:Dec.)
- Journal:
- Clinical cardiology
- Issue:
- Volume 37:Issue 12(2014:Dec.)
- Issue Display:
- Volume 37, Issue 12 (2014)
- Year:
- 2014
- Volume:
- 37
- Issue:
- 12
- Issue Sort Value:
- 2014-0037-0012-0000
- Page Start:
- 744
- Page End:
- 749
- Publication Date:
- 2014-11-17
- Subjects:
- Cardiology -- Periodicals
616.12005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1932-8737/issues ↗
http://www3.interscience.wiley.com/journal/113412417/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/clc.22336 ↗
- Languages:
- English
- ISSNs:
- 0160-9289
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.265000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3740.xml